title: Increased neointimal formation after surgical vein grafting in a murine model of type 2 diabetes.
abstract: BACKGROUND
  Diabetes is an independent risk factor for the development of neointimal hyperplasia and subsequent vein graft failure after coronary or peripheral artery bypass grafting. We evaluate a new mouse model of surgical vein grafting to investigate the mechanisms of neointimal formation in the setting of type 2 diabetes.
  
  
  RESULTS
  Surgical vein grafts were created by inserting vein segments from age-matched C57BL/KsJ wild-type mice into the infra-renal aorta of lepr(db/db) diabetic and C57BL/KsJ wild-type mice. Mice were euthanized &4 weeks later, and vein grafts were analyzed using morphometric and immunohistochemical techniques. A significant increase in neointimal formation was noted in lepr(db/db) mice (139+/-64 versus 109+/-62 mm2; P=0.008) after 4 weeks. This difference was mainly secondary to an increase in collagen formation within the lesion in the vein grafts from lepr(db/db) mice (0.53+/-0.4 versus 0.44+/-0.05; P<0.001), whereas only slight increases (P=not significant) in alpha actin-stained smooth muscle cells were noted in the lepr(db/db) mice.
  
  
  CONCLUSIONS
  We established a new physiologically relevant model of surgical vein grafting in mice. In this report, type 2 diabetes was associated with significant increase in extracellular matrix deposition in addition to increased smooth muscle cell deposition. This new model may allow mechanistic studies of cellular and molecular pathways of increased neointimal formation in the setting of diabetes.
authors.affiliation: Department of Cardiothoracic Surgery, Mount Sinai Medical Center, 1190 Fifth Ave, Box 1028, New York, NY 10029, USA. sacha.salzberg@gmail.com
authors.forename: Sacha P
authors.initials: SP
authors.lastname: Salzberg
authors.forename: Farzan
authors.initials: F
authors.lastname: Filsoufi
authors.forename: Anelechi
authors.initials: A
authors.lastname: Anyanwu
authors.forename: Kai
authors.initials: K
authors.lastname: von Harbou
authors.forename: Eva
authors.initials: E
authors.lastname: Karlof
authors.forename: Alain
authors.initials: A
authors.lastname: Carpentier
authors.forename: Hayes M
authors.initials: HM
authors.lastname: Dansky
authors.forename: David H
authors.initials: DH
authors.lastname: Adams
mesh_terms: D000199:Actins / Q000096:biosynthesis; D000818:Animals; D001012:Aorta, Abdominal / Q000601:surgery*; D001705:Bioprosthesis; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation; D003094:Collagen / Q000096:biosynthesis; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000235:genetics; D004195:Disease Models, Animal; D004549:Elastin / Q000032:analysis; D005109:Extracellular Matrix / Q000378:metabolism; D006965:Hyperplasia; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D009131:Muscle, Smooth, Vascular / Q000378:metabolism / Q000473:pathology; D011956:Receptors, Cell Surface / Q000172:deficiency / Q000235:genetics; D054411:Receptors, Leptin; D016042:Transplantation, Heterotopic; D017539:Tunica Intima / Q000473:pathology*; D014682:Vena Cava, Inferior / Q000473:pathology / Q000637:transplantation*
chemical_list: D000199:Actins; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D003094:Collagen; D004549:Elastin